Here are four key notes:
1. Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space.
2. Collagen Solutions is a developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics.
3. The supply agreement encompasses additional collagen material sources for use in Histogenics’ investigational product candidate, NeoCart.
4. NeoCart is a regenerative medicine product currently in phase 3 clinical trials.
5. The supply agreement may also encompass additional future products in the Histogenics pipeline for markets outside of the United States.
More articles on devices:
Illinois woman sues orthopedic surgeon alleging negligence resulting in amputation — 5 key notes
CNS meeting to include Mazor’s spine surgery robot on live-steam: 3 key notes
Medical device start-ups: 5 companies to note
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
